(Q34733828)

4 August 2017

Weight gain and new onset diabetes associated with olanzapine and risperidone (English)

1 reference

4 August 2017

1 reference

1 reference

Wildon R Farwell

1

1 reference

4 August 2017

Timothy E Stump

2

1 reference

4 August 2017

Jane Wang

3

1 reference

4 August 2017

Eskinder Tafesse

4

1 reference

4 August 2017

Gilbert L'Italien

5

1 reference

4 August 2017

William M Tierney

6

1 reference

4 August 2017

1 December 2004

1 reference

Journal of General Internal Medicine

4 August 2017

1 reference

4 August 2017

19

1 reference

4 August 2017

12

1 reference

4 August 2017

1200-1205

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1525-1497.2004.40126.x

4 August 2017

0 references

cites work

Trends and correlates of class 3 obesity in the United States from 1990 through 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Review of atypical antipsychotics and weight gain.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Hyperglycemia associated with the use of atypical antipsychotics.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

The pharmacology of weight gain with antipsychotics.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Antipsychotic-induced weight gain: a review of the literature

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Bodyweight gain with atypical antipsychotics. A comparative review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Atypical antipsychotics and weight gain--a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Pharmacologic treatment of schizophrenia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Weight gain associated with use of psychotropic medications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

The Regenstrief Medical Record System: a quarter century experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Differences in weight gain in relation to race, gender, age and education in young adults: the CARDIA Study. Coronary Artery Risk Development in Young Adults.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Dosing the antipsychotic medication olanzapine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Weight Changes With Schizophrenic Psychosis and Psychotropic Drug Therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.40126.X

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.40126.X

Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.40126.X

Risperidone-associated new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.40126.X

Changes in body mass index for individuals with and without schizophrenia, 1987–1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.40126.X

A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Body weight and leptin plasma levels during treatment with antipsychotic drugs

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492596

Weight changes during treatment with phenothiazine derivatives

26 October 2018

1 reference

12 December 2020

Diabetes as a result of atypical anti-psychotic drugs--a report of three cases

1 reference

12 December 2020

A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States

1 reference

12 December 2020

Seven-year trends in body weight and associations with lifestyle and behavioral characteristics in black and white young adults: the CARDIA study

1 reference

12 December 2020

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

1 reference

12 December 2020

10.1111/J.1525-1497.2004.40126.X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference